Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data

By afschroeder • August 29, 2025

Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali S, Krishnaswamy A, Whisenant B, Menees D, Lim DS, Gilani F, Sanchez CE, Gheewala N, Gada H, Kapadia S, Ramanathan PK, Shah PB, Renard B, Theodos G, Yaryura R, Gardner B, Steinberg DH, Gnall E, Kaddissi G, Chhatriwalla AK, Frangieh AH, Eleid MF, Géneréux P, Saxon JT, Villablanca P, Matar F, Agarwal H, Chetcuti S, Frisoli T, Makkar R. Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data. JACC Cardiovasc Interv. 2025 Aug 25;18(16):2036-2046. doi: 10.1016/j.jcin.2025.07.019. PMID: 40866033.

Tags: Cardiology/Epi, Cedars Sinai DoM, degenerative mitral regurgitation, DMR, M-TEER, mitral valve transcatheter edge-to-edge repair, PASCAL system, Publications

Insurance-Based Disparities in Cardiac Allograft Vasculopathy After Heart Transplantation Are Mediated by Care at High-Volume Centers

Sakowitz S, Bakhtiyar SS, Mallick S, Pereira S, Nelson JS, Parikh R, Higgins RSD, Shemin RJ, Benharash P. Insurance-Based Disparities in Cardiac Allograft Vasculopathy After[...]

Engineering noncovalent π-stacked organic framework for intrinsic near-infrared photoactivated drug delivery

Fu R, Meng D, Han X, Liu L, Chen C, Zheng R, Zhao Y, Zhang X, Lin X, Hasani M, Song Y, Liang T, Wen[...]

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome

Gajjar A, Raju AK, Gajjar A, Menon M, Shah SAY, Dani S, Weinberg A. SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome. Biomedicines. 2025[...]